BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8127253)

  • 21. Glucocorticoid resistance in childhood leukemia.
    Kaspers GJ; Pieters R; Klumper E; De Waal FC; Veerman AJ
    Leuk Lymphoma; 1994 Apr; 13(3-4):187-201. PubMed ID: 8049644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Asparaginase Therapy in Pediatric Acute Lymphoblastic Leukemia: A Focus on the Mode of Drug Resistance.
    Chen SH
    Pediatr Neonatol; 2015 Oct; 56(5):287-93. PubMed ID: 25603726
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Topoisomerase II alpha gene expression in childhood acute lymphoblastic leukemia.
    Klumper E; Giaccone G; Pieters R; Broekema G; van Ark-Otte J; van Wering ER; Kaspers GJ; Veerman AJ
    Leukemia; 1995 Oct; 9(10):1653-60. PubMed ID: 7564505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug-resistance Profile in Multiple-relapsed Childhood Acute Lymphoblastic Leukemia.
    Pogorzala M; Kubicka M; Rafinska B; Wysocki M; Styczynski J
    Anticancer Res; 2015 Oct; 35(10):5667-70. PubMed ID: 26408741
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro comparative antileukemic activity of various glucocorticoids in childhood acute leukemia.
    Styczyński J; Wysocki M; Balwierz W; Rokicka-Milewska R; Matysiak M; Balcerska A; Kowalczyk A; Wachowiak J; Sońta-Jakimczyk D; Chybicka A
    Neoplasma; 2002; 49(3):178-83. PubMed ID: 12098004
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro sensitivity of leukemic cells to nucleoside derivatives in childhood acute leukemias: good activity in leukemic relapses.
    Styczynski J; Wysocki M; Debski R; Czyzewski K; Balwierz W; Juraszewska E; Matysiak M; Malinowska I; Stanczak E; Sońta-Jakimczyk D; Szczepanski T; Wachowiak J; Konatkowska B; Balcerska A; Ploszynska A; Kowalczyk J; Stefaniak J; Badowska W; Wieczorek M; Olejnik I; Krawczuk-Rybak M; Kuzmicz M
    Neoplasma; 2005; 52(1):74-8. PubMed ID: 15739031
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cellular drug sensitivity of immunophenotypic subgroups of childhood acute lymphoblastic leukemia.
    Pieters R; Kaspers GJ; van Wering ER; Huismans DR; Loonen AH; Hählen K; Veerman AJ
    Recent Results Cancer Res; 1993; 131():249-56. PubMed ID: 8210644
    [No Abstract]   [Full Text] [Related]  

  • 28. Prednisolone resistance in childhood acute lymphoblastic leukemia: vitro-vivo correlations and cross-resistance to other drugs.
    Kaspers GJ; Pieters R; Van Zantwijk CH; Van Wering ER; Van Der Does-Van Den Berg A; Veerman AJ
    Blood; 1998 Jul; 92(1):259-66. PubMed ID: 9639525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relation of cellular drug resistance to long-term clinical outcome in childhood acute lymphoblastic leukaemia.
    Pieters R; Huismans DR; Loonen AH; Hählen K; van der Does-van den Berg A; van Wering ER; Veerman AJ
    Lancet; 1991 Aug; 338(8764):399-403. PubMed ID: 1678081
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ex vivo drug resistance profile in childhood acute myelogenous leukemia: no drug is more effective in comparison to acute lymphoblastic leukemia.
    Styczynski J; Wysocki M; Debski R; Juraszewska E; Malinowska I; Stanczak E; Ploszynska A; Stefaniak J; Mazur B; Szczepanski T
    Leuk Lymphoma; 2002 Sep; 43(9):1843-8. PubMed ID: 12685842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased in vitro cellular drug resistance is related to poor outcome in high-risk childhood acute lymphoblastic leukaemia.
    Frost BM; Nygren P; Gustafsson G; Forestier E; Jonsson OG; Kanerva J; Nygaard R; Schmiegelow K; Larsson R; Lönnerholm G;
    Br J Haematol; 2003 Aug; 122(3):376-85. PubMed ID: 12877664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical importance of myeloid-antigen expression in acute lymphoblastic leukemia of childhood.
    Wiersma SR; Ortega J; Sobel E; Weinberg KI
    N Engl J Med; 1991 Mar; 324(12):800-8. PubMed ID: 1997852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Corticosteroid resistance is increased in lymphoblasts from adults compared with children: preliminary results of in vitro drug sensitivity study in adults with acute lymphoblastic leukaemia.
    Maung ZT; Reid MM; Matheson E; Taylor PR; Proctor SJ; Hall AG
    Br J Haematol; 1995 Sep; 91(1):93-100. PubMed ID: 7577660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cross-resistance to five glucocorticoids in childhood acute lymphoblastic and non-lymphoblastic leukemia samples tested by the MTT assay: preliminary report.
    Styczyński J; Wysocki M; Debski R; Balwierz W; Rokicka-Milewska R; Matysiak M; Balcerska A; Kowalczyk J; Wachowiak J; Sońta-Jakimczyk D; Chybicka A
    Acta Biochim Pol; 2002; 49(1):93-8. PubMed ID: 12136961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myeloid antigen co-expression in childhood acute lymphoblastic leukaemia: relationship with in vitro drug resistance.
    Den Boer ML; Kapaun P; Pieters R; Kazemier KM; Janka-Schaub GE; Veerman AJ
    Br J Haematol; 1999 Jun; 105(4):876-82. PubMed ID: 10554796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparative study of clinical features of childhood and adult acute lymphoblastic leukemia].
    Liu X; Xia X; Li J; He H; Chou H; Zhu L
    Zhonghua Xue Ye Xue Za Zhi; 2000 Jan; 21(1):14-6. PubMed ID: 11876953
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of mercaptopurine (6MP) metabolites and 6MP metabolic key-enzymes in childhood acute lymphoblastic leukemia.
    Wojtuszkiewicz A; Barcelos A; Dubbelman B; De Abreu R; Brouwer C; Bökkerink JP; de Haas V; de Groot-Kruseman H; Jansen G; Kaspers GL; Cloos J; Peters GJ
    Nucleosides Nucleotides Nucleic Acids; 2014; 33(4-6):422-33. PubMed ID: 24940700
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of cytotoxicity by flow cytometric drug sensitivity assay in childhood T-cell acute lymphoblastic leukemia.
    Savaşan S; Buck S; Ozdemir O; Hamre M; Asselin B; Pullen J; Ravindranath Y
    Leuk Lymphoma; 2005 Jun; 46(6):833-40. PubMed ID: 16019527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro cytotoxicity of mitoxantrone, daunorubicin and doxorubicin in untreated childhood acute leukemia.
    Kaspers GL; Veerman AJ; Pieters R; van Zantwijk I; Klumper E; Hählen K; de Waal FC; van Wering ER
    Leukemia; 1994 Jan; 8(1):24-9. PubMed ID: 8289494
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of the multidrug transporter P-glycoprotein is highly correlated with clinical outcome in childhood acute lymphoblastic leukemia: results of a long-term prospective study.
    Dhooge C; De Moerloose B; Laureys G; Ferster A; De Bacquer D; Philippe J; Leroy J; Benoit Y
    Leuk Lymphoma; 2002 Feb; 43(2):309-14. PubMed ID: 11999562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.